Alkermes’ Corporate Presentation to be Webcast at the 35th Annual J.P. Morgan Healthcare Conference
January 03 2017 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the 35th Annual J.P. Morgan
Healthcare Conference on Tuesday, Jan. 10, 2017 at 10:30 a.m. PT
(1:30 p.m. ET/6:30 p.m. GMT) from the Westin St. Francis Hotel in
San Francisco. The presentation will be followed by a question and
answer session that will begin at 11:00 a.m. PT (2:00 p.m. ET/7:00
p.m. GMT). A webcast of both the presentation and question and
answer session may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170103005961/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024